Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced the appointment of Dr. Laura Saward, PhD, as the company's Chief Scientific ...

GENERALLY, A CHRONIC illness is a medical condition that lasts for six months or longer, usually requires ongoing care and treatment, and may limit your daily activities, says Sumanth Prabhu, M.D., ...

Extensive testing ruled out an infectious cause or inflammatory ... A differential diagnosis should also be considered with IBD [Ulcerative colitis/Chron’s Disease (UC/CD)], as associations between MS ...

Deutsche Bank (ETR:DBKGn) initiated coverage on Denali Therapeutics Inc. (NASDAQ: NASDAQ:DNLI) with a Buy rating and set a price target of $31.00. The new assessment comes as Denali's shares are seen ...

We recently compiled a list of the Top 10 Stocks to Buy According to Lee Munder Capital Group. In this article, we are going ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Opening up can unlock much-needed support, but it also comes with risks. The flare-up started like all of the others: intense ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...